Effect of Formulation Parameters on Skin Flux of Demopressin Microemulsion

Document Type : Research Note


1 Biomedical Engineering Group, Chemical Engineering Faculty, Tarbiat Modares University, P.O. Box 14155-143 Tehran, I.R. IRAN

2 Novel Drug Delivery Systems Department, Polymer Science Faculty, Iran Polymer and Petrochemical Institute, P.O. Box 14965-115 Tehran, I.R. IRAN


Transdermal drug delivery systems are considered in recent years as a promising alternative to oral delivery and hypodermic injections.The present work reports on the development of water-in-oil (w/o) emulsions for the transdermal administration of desmopressin acetate. Microemulsion components included: Tween80 and Span80 (surfactants), 1-decanol (co-surfactant), and isopropyl myristate (oil phase). The effects of formulation components, hydrophilic-lipophilic balance (HLB,7-9 ), ratio of surfactants and co-surfactant mixture to oil phase (Smix/oil,5:5-7:3) and ratio of surfactants to co-surfactant (S/Cs, 2:1- 5:1) on skin flux was evaluated using Design-Expert software 7.0.0. It was concluded that skin flux was increased when S/Cs and Smix/oil were decreased and by increasing HLB skin flux enhanced. The following optimized formulation was obtained by the software: HLB = 8, S/Cs = 3, and Smix/oil = 5.46. Stability and skin permeation of optimized formulation was measured. Based on the results of this research, by reducing the viscosity and increasing the system polarity, drug skin flux of microemulsion increases. Studies of skin permeation show that transdermal drug delivery of large-molecule drugs because of small dimensions and ingredients that act as skin enhancers are possible.


Main Subjects

[2] Melkamu G., Wohlrab J., Neubert, H.H.R.Dermal Delivery of Desmopressin Acetate Using Colloidal Carrier Systems, Journal of Pharmacy and Pharmacology, 57: 423–427 (2005).
[3] Murthy S.N., Shivakumar H.N., "Topical and Transdermal Drug Delivery, Handbook of Non-Invasive Drug Delivery Systems", Vitthal S. Kulkarni, 1st Ed, NewYork, Elsevier Inc, p. 26 (2010).
[5] Fana Q., Sirkar K.K., Wangb Y., Michniakc B. In Vitro Delivery of Doxycycline Hydrochloride Based on a Porous Membrane-Based Aqueous-Organic Partitioning System, Journal of Controlled Release, 98: 355-65 (2004).
[6] Zhao X., Liu J.P., Zhang X., Li Y., Enhancement of Transdermal Delivery of Theophylline Using Microemulsion Vehicle, International Journal of Pharmaceutics, 327: 58-64 (2006).
[7] Karasulu H.Y., Microemulsions as Novel Drug carriers: the Formation, Stability, Applications and Toxicity, Expert Opinion on Drug Delivery, 5(1): 119-35 (2008).
[8] عبدخدایی، محمد جعفر؛ کاربردهای مهندسی شیمی در پزشکی یا گرایش مهندسی پزشکی در مهندسی شیمی، نشریه شیمی و مهندسی شیمی ایران، (1)18: 66 ـ 57 (1378).
[9] Kogan, A., Garti, N. Microemulsions as Transdermal Drug Delivery Vehicles., Advanced Colloid and Interface Science, 123(126): 369-385 (2006).
[10] Patel M.R., Patel R.B., Parikh J.R., Solanki A.B., Patel B.G., Effect of Formulation Components on the in Vitro Permeation of Microemulsion Drug Delivery System of Fluconazole, A.A.P.S. Pharmaceutical Scientist Technology, 10(3): 917-923 (2009).
[12] Rao Y.S., Deepthi K.S., Chowdary K.P.R., Microemulsions: a Novel Drug Carrier System, International Journal of Drug Delivery Technology, 1(2): 39-41 (2009).
[15] Karande P., Mitragotri S., Enhancement of Transdermal Drug Delivery via Synergistic Action of Chemicals, Biochemical and Biophysics Acta, 1788: 2362-2373 (2009).